What's in Joslin Diabetes Center's pipeline?

Joslin Diabetes Center has 2 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Joslin Diabetes Center's portfolio?

Top competitors by shared drug class: Eli Lilly and Company, AJU Pharm Co., Ltd., Aciex Therapeutics, Inc., Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/joslin-diabetes-center.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Joslin Diabetes Center — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Joslin Diabetes Center pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Calcitriol (Rocaltrol®)	Calcitriol (Rocaltrol®)	marketed	Vitamin D analog	Vitamin D receptor (VDR)	Endocrinology
CIIIT	CIIIT	phase 3	SGLT2 inhibitor	SGLT2	Diabetes

Therapeutic area mix

Diabetes · 1
Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Eli Lilly and Company · 2 shared drug classes
AJU Pharm Co., Ltd. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
AO GENERIUM · 1 shared drug class
ADvantage Therapeutics · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Joslin Diabetes Center:

Cite this brief

Drug Landscape (2026). Joslin Diabetes Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/joslin-diabetes-center. Accessed 2026-05-16.